Nairoviridae

Nairoviridae is a family of viruses in the order Bunyavirales. This family includes viruses that are primarily transmitted by ticks and are known to cause disease in humans and animals. The most notable member of this family is the Crimean-Congo hemorrhagic fever virus (CCHFV), which is responsible for causing severe hemorrhagic fever in humans.

Structure

Nairoviruses are enveloped viruses with a spherical to pleomorphic shape. They have a segmented, negative-sense, single-stranded RNA genome. The genome is divided into three segments: the large (L), medium (M), and small (S) segments. The L segment encodes the RNA-dependent RNA polymerase, the M segment encodes the glycoproteins, and the S segment encodes the nucleocapsid protein.

Transmission

Nairoviruses are primarily transmitted through the bite of infected ticks. They can also be transmitted through contact with infected animal blood or tissues, and in some cases, human-to-human transmission can occur, particularly in healthcare settings.

Pathogenesis

The pathogenesis of nairovirus infections involves the virus entering the host through a tick bite or contact with infected materials. Once inside the host, the virus targets endothelial cells, hepatocytes, and immune cells, leading to widespread vascular damage, liver dysfunction, and immune dysregulation. This can result in severe hemorrhagic manifestations and multi-organ failure.

Clinical Manifestations

Infections with nairoviruses can range from mild febrile illness to severe hemorrhagic fever. The incubation period is typically 1-3 days following a tick bite and up to 9 days following contact with infected blood or tissues. Symptoms include sudden onset of fever, myalgia, dizziness, neck pain, and stiffness. Severe cases can progress to hemorrhagic symptoms, including petechiae, ecchymosis, and bleeding from mucous membranes.

Diagnosis

Diagnosis of nairovirus infections is primarily based on clinical suspicion and confirmed through laboratory testing. Methods include serological assays to detect specific antibodies, reverse transcription-polymerase chain reaction (RT-PCR) to detect viral RNA, and virus isolation in cell culture.

Treatment and Prevention

There is no specific antiviral treatment for nairovirus infections. Management is primarily supportive, focusing on maintaining fluid balance, correcting electrolyte imbalances, and providing supportive care for organ dysfunction. Ribavirin has been used in some cases with variable success.

Prevention strategies include avoiding tick bites through the use of protective clothing and repellents, controlling tick populations, and implementing infection control measures in healthcare settings to prevent nosocomial transmission.

Epidemiology

Nairoviruses are distributed worldwide, with a higher prevalence in Africa, Asia, and Eastern Europe. The distribution is closely linked to the habitat of the tick vectors. Outbreaks of Crimean-Congo hemorrhagic fever have been reported in several countries, highlighting the public health importance of these viruses.

Also see

• Bunyavirales
• Crimean-Congo hemorrhagic fever
• Tick-borne diseases
• Viral hemorrhagic fevers